Join our presentation at the World ADC San Diego 2024
Join Dr. Art Hsing-Mao Chu, CEO of T-E Meds, at World ADC San Diego 2024 on Nov 4th to hear
Meeing
Meeing
We will be participating in the 8th Taiwan Healthcare+ Expo Taiwan. Welcome to visit us
The annual Taiwan Healthcare+ Expo will be held from December 5 to 8, 2024, at Hall 1 of the Nangang
Meeing
Join our presentation at the ACCESS CHINA Partnering Forum
Dr. Kun-Po Li, the director of business development of Immunwork, will be presenting at the ACCESS CHINA Partnering Forum –
R&D Progress
Two ultra-long acting drugs receive promising news! Phase 1 clinical trials are expected to be completed next year!
Immunwork announced that two ultra-long-acting drugs developed using innovative fatty acid bundles technology platform have received approval from the Australian
Meeing
Join our presentation at the BIO Asia-Taiwan 2024 Conference
We are proud to share that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, was invited to present at the
Meeing
Join our presentation at the World ADC Asia 2024 Conference
Dr. Tse Wen Chang, Chairman and CEO of Immunwork, and Dr. Art Hsing-Mao Chu, CEO of T-E Meds, have been
Reported
The 2024 Tang Prize is awarded to three scientists for the development of GLP-1
The 2024 Tang Prize in Biopharmaceutical Science has cast a spotlight on GLP-1 receptor agonists, sparking a global race among
Scientific Publication
Our latest research result is published in Advanced Science
Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform! We are thrilled
Meeing
Join Our presentation at The BiG ADC/XDC Conference
Dr. Kun-Po Li, BD Director of T-E Meds, an is set to captivate the audience at The BiG ADC/XDC Conference
Meeing
Join Our presentation at The 5th ADC Development Summit
We’re thrilled to announce that Dr. Hsing-Mao Chu, CEO of T-E Meds is honored to present at The 5th ADC